does medicare pay for glp 1 for weight loss Spending on Ozempic and Other GLP-1s Is Skyrocketing Some Medicare patients will be

Additionally, patients experienced modest weight loss averaging 2 to 3 kg over 6 months, an unexpected but welcome effect that distinguished GLP-1 receptor agonists from many other diabetes medications that cause weight gain

While this metabolic effect supports weight management, the primary driver of GLP-1mediated weight loss is reduced calorie intake rather than a substantial increase in energy expenditure

[13] Treatment was given for 30 weeks

In humans, metabolically healthy obesity is associated with smaller adipocytes and a lower visceral-to-subcutaneous fat ratio, whereas expansion of visceral fat correlates with systemic insulin resistance and ectopic lipid deposition 46,47,48

kidney stones